Symbol | Mkt Cap | P/E | Current Ratio | Cash per Share | Operating Margin | EBIDTA Margin | Revenue Growth | Earnings Growth | H-Rank | C-Rank | Stars |
GRFS | 6.0 B | 6.6 | 2.7 | 1.48 | 21 | 22 | 11 | 82 | 18 | 1 | 3 |
MRK | 209 B | 8.8 | 5.42 | 39 | 45 | -1.6 | 7.3 | 27 | 1 | 2 | |
NVO | 306 B | 17 | 0.74 | 5.92 | 49 | 50 | 30 | 29 | 21 | 2 | 3 |
NVS | 226 B | 13 | 0.79 | 3.66 | 35 | 41 | 12 | 38 | 23 | 2 | 2 |
BIIB | 18 B | 7.4 | 1.4 | 17.73 | 28 | 31 | 6.1 | -39 | 23 | 2 | 1 |
JNJ | 376 B | 14 | 1.3 | 16.12 | 29 | 33 | 2.4 | 238 | 23 | 2 | 1 |
AZN | 225 B | 13 | 0.90 | 3.48 | 27 | 33 | 7.2 | 33 | 24 | 2 | 0 |
GSK | 79 B | 9.1 | 0.87 | 1.10 | 30 | 27 | 2.1 | 54 | 25 | 2 | 0 |
OGN | 2.5 B | 2.3 | 1.7 | 2.12 | 21 | 26 | -6.7 | -57 | 25 | 2 | 2 |
PFE | 137 B | 8.3 | 3.61 | 35 | 37 | -7.8 | -5.3 | 28 | 2 | 2 | |
LLY | 740 B | 36 | 1.4 | 3.59 | 42 | 44 | 45 | 23 | 20 | 3 | 2 |
ABBV | 351 B | 16 | 3.15 | 29 | 47 | 8.4 | -6.3 | 26 | 3 | 1 | |
SNY | 135 B | 11 | 6.03 | 20 | 26 | -4.6 | 67 | 29 | 3 | 1 | |
AMGN | 151 B | 13 | 1.2 | 16.38 | 28 | 46 | 9.4 | 31 | 5 | 1 | |
BMY | 103 B | 7.2 | 1.3 | 5.79 | 31 | 40 | -5.6 | 32 | 5 | 1 | |
GILD | 129 B | 13 | 1.3 | 6.37 | 38 | 47 | -0.30 | 32 | 6 | 2 | |
MIRA | 20 M | -2.4 | 4.0 | 0.17 | 0.00 | 0.00 | 54 | 26 | 1 | ||
AMRN | 226 M | -51 | 3.3 | 0.71 | -25 | -22 | -16 | 65 | 37 | 1 | |
SCLX | 28 M | -13 | 0.16 | 0.62 | -190 | -156 | 10.0 | 73 | 47 | 0 | |
Q1 = 8.3 | Q3 = 1.7 | Q3 = 35 | Q3 = 45 | Q3 = 12 | Q3 = 67 |
Total Records: 19. | Quotes | Help |
© George Elgin | Questions or Comments | Data last Modified 05/04/25 |